Aristeia Capital’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$813K Sell
25,103
-5,090
-17% -$131K 0.01% 336
2026
Q1
$554K Buy
+30,193
New +$574K 0.01% 343
2025
Q4
Sell
-15,265
Closed -$296K 614
2025
Q3
$296K Buy
+15,265
New +$298K 0.01% 338
2025
Q2
Sell
-9,983
Closed -$244K 489
2025
Q1
$244K Sell
9,983
-1,908
-16% -$49K 0.01% 296
2024
Q4
$284K Buy
11,891
+1,105
+10% +$35.1K 0.01% 250
2024
Q3
$457K Buy
10,786
+928
+9% +$48.7K 0.01% 188
2024
Q2
$505K Buy
+9,858
New +$559K 0.01% 160

Other funds holding AMN

Aristeia Capital's AMN Position: Q2 2026 in Review

Aristeia Capital reduced its AMN Healthcare (AMN) stake by 17% in Q2 2026, selling an estimated $131K and leaving 25,103 shares worth $813K. The position accounts for 0.01% of the portfolio, ranked #336.

Aristeia Capital first reported a position in AMN in Q2 2024 and has held it in 7 quarters since. 286 funds tracked by Wall St. Rank hold AMN as of Q2 2026.

  • Aristeia Capital held 25,103 shares of AMN Healthcare worth $813K as of Q2 2026.
  • Aristeia Capital sold 5,090 AMN Healthcare shares in Q2 2026, an estimated $131K.
  • AMN Healthcare made up 0.01% of Aristeia Capital's portfolio in Q2 2026, its #336 holding.
  • Aristeia Capital first reported a position in AMN Healthcare in Q2 2024 and has held it in 7 quarters since.
  • 286 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.